Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Marie Nancy, Séraphin"'
Autor:
Marie Nancy Séraphin, Julia Bellot, Emily Klann, Maria Ukhanova, Florence G. Saulsberry, Charles A. Peloquin, Volker Mai
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Tuberculosis (TB) preventive therapy (TPT) is an effective strategy to eliminate TB in low-incidence settings. Shorter TPT regimens incorporating the antimicrobial class of rifamycins are designed to improve adherence and completion rates bu
Externí odkaz:
https://doaj.org/article/1e04c22e3e8145f8834ea37a5e4faa4d
Autor:
Muhammad Asghar, Taj Ali Khan, Marie Nancy Séraphin, Lena F. Schimke, Otavio Cabral-Marques, Ihtisham Ul Haq, Zia-ur-Rehman Farooqi, Susana Campino, Ihsan Ullah, Taane G. Clark
Publikováno v:
Antibiotics, Vol 13, Iss 8, p 765 (2024)
Background: Typhoid fever caused by Salmonella enterica serovar Typhi (S. typhi) continues to pose a significant risk to public health in developing countries, including Pakistan. This study investigated the epidemiological factors linked to suspecte
Externí odkaz:
https://doaj.org/article/813b6c8cbb864413aeeedb23cc825e01
Publikováno v:
BMC Research Notes, Vol 16, Iss 1, Pp 1-4 (2023)
Abstract Objective We present 16s rRNA gene sequencing (V1-V2 region) and sample data from a pilot observational cohort study to describe the gut microbiota dynamics of subjects with latent tuberculosis infection (LTBI) treated with daily 600 mg rifa
Externí odkaz:
https://doaj.org/article/29872272bffa4880b4eec674bc81671a
Autor:
Jane S. Afriyie-Mensah, Robert Aryee, Francisca Zigah, Ernest Amaning-Kwarteng, Marie Nancy Séraphin
Publikováno v:
Tuberculosis Research and Treatment, Vol 2023 (2023)
Aim. We aimed to investigate the demographic and clinical factors associated with TB mortality in patients managed at a tertiary TB referral center. Methods. We conducted a retrospective review of the medical records of 1,933 TB patients seen between
Externí odkaz:
https://doaj.org/article/2e64f52a801b4dcdad49801c2dc14ba5
Autor:
Nana Ayegua Hagan Seneadza, Awewura Kwara, Michael Lauzardo, Cindy Prins, Zhi Zhou, Marie Nancy Séraphin, Nicole Ennis, Jamie P. Morano, Babette Brumback, Robert L. Cook
Publikováno v:
PLoS ONE, Vol 17, Iss 8 (2022)
Purpose This study examined factors associated with TB among persons living with HIV (PLWH) in Florida and the agreement between self-reported and medically documented history of tuberculosis (TB) in assessing the risk factors. Methods Self-reported
Externí odkaz:
https://doaj.org/article/f4f121d807274bdcbefc46ff1f6b040f
Autor:
Marie Nancy Séraphin, Anders Norman, Erik Michael Rasmussen, Alexandra M. Gerace, Calin B. Chiribau, Marie-Claire Rowlinson, Troels Lillebaek, Michael Lauzardo
Publikováno v:
EBioMedicine, Vol 47, Iss , Pp 293-300 (2019)
Background: Whole genome sequencing (WGS) has enabled the development of new approaches to track Mycobacterium tuberculosis (Mtb) transmission between tuberculosis (TB) cases but its utility may be challenged by the discovery that Mtb diversifies wit
Externí odkaz:
https://doaj.org/article/74fe3cc4d43840159214402be6cc2df4
Autor:
Marie Nancy Séraphin, HsiaoChu Hsu, Helena J. Chapman, Joanne L. de Andrade Bezerra, Lori Johnston, Yang Yang, Michael Lauzardo
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Treatment of latent tuberculosis infection (LTBI) in high-risk groups is an effective strategy for TB control and elimination in low incidence settings. A nine-month course of daily isoniazid (INH) has been the longest prescribed
Externí odkaz:
https://doaj.org/article/8d67ef8c13fe4f08bd785fdfab4c2253
Autor:
Marie Nancy Séraphin, Julia Bellot, Emily Klann, Maria Ukhanova, Florence G. Saulsberry, Charles A. Peloquin, Volker Mai
Background: Latent tuberculosis infection (LTBI) treatment is an effective strategy to eliminate TB in low-incidence settings. Shorter LTBI regimens incorporating the antimicrobial class of rifamycins are designed to improve treatment completion rate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f66f49084b4001e11bcb2090f8829ca5
https://doi.org/10.21203/rs.3.rs-2313802/v1
https://doi.org/10.21203/rs.3.rs-2313802/v1
Autor:
Daniela Munro-Rojas, Esdras Fernandez-Morales, José Zarrabal-Meza, Ma Teresa Martínez-Cazares, Aurora Parissi-Crivelli, Javier Fuentes-Domínguez, Marie Nancy Séraphin, Michael Lauzardo, Jorge Alberto González-Y-Merchand, Sandra Rivera-Gutierrez, Roberto Zenteno-Cuevas
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193626 (2018)
BACKGROUND:Mexico is one of the most important contributors of drug and multidrug-resistant tuberculosis in Latin America; however, knowledge of the genetic diversity of drug-resistant tuberculosis isolates is limited. METHODS:In this study, the gene
Externí odkaz:
https://doaj.org/article/644e77ea99f742b68a500542c5052351
Objective: We present 16s rRNA gene sequencing (V1-V2 region) and sample data from a pilot observational cohort study to describe the gut microbiota dynamics in patients with latent tuberculosis infection (LTBI) treated with a three to four-month cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::785103df4a0abd989110499fc18605eb
https://doi.org/10.21203/rs.3.rs-2199576/v1
https://doi.org/10.21203/rs.3.rs-2199576/v1